Literature DB >> 26301975

Frailty: Scaling from Cellular Deficit Accumulation?

Kenneth Rockwood1, Arnold Mitnitski, Susan E Howlett.   

Abstract

Cells age in association with deficit accumulation via mechanisms that are far from fully defined. Even so, how deficits might scale up from the subcellular level to give rise to clinically evident age-related changes can be investigated. This 'scaling problem' can be viewed either as a series of little-related events that reflect discrete processes--such as the development of particular diseases--or as a stochastic process with orderly progression at the systems level, regardless of which diseases are present. Some recent evidence favors the latter hypothesis, but determining the best approach to study how deficits scale remains a key goal for understanding aging. In consequence, approaching the problem of frailty as one of the scaling of subcellular deficits has implications for understanding aging. Considering the cumulative effects of many small deficits appears to allow for the observation of important aspects of the behavior of systems that are close to failure. Mathematical modeling offers useful possibilities in clarifying the extent to which different clinical scales measure different phenomena. Even so, to be useful, mathematical modelling must be clinically coherent in addition to mathematically sound. In this regard, queuing appears to offer some potential for investigating how deficits originate and accumulate. 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2015        PMID: 26301975     DOI: 10.1159/000381127

Source DB:  PubMed          Journal:  Interdiscip Top Gerontol Geriatr        ISSN: 2297-3486


  8 in total

1.  The impact of age and frailty on ventricular structure and function in C57BL/6J mice.

Authors:  H A Feridooni; A E Kane; O Ayaz; A Boroumandi; N Polidovitch; R G Tsushima; R A Rose; S E Howlett
Journal:  J Physiol       Date:  2017-05-14       Impact factor: 5.182

2.  A Murine Frailty Index Based on Clinical and Laboratory Measurements: Links Between Frailty and Pro-inflammatory Cytokines Differ in a Sex-Specific Manner.

Authors:  Alice E Kane; Kaitlyn M Keller; Stefan Heinze-Milne; Scott A Grandy; Susan E Howlett
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2019-02-15       Impact factor: 6.053

3.  Frailty Assessment in Hospitalized Older Adults Using the Electronic Health Record.

Authors:  Deborah A Lekan; Debra C Wallace; Thomas P McCoy; Jie Hu; Susan G Silva; Heather E Whitson
Journal:  Biol Res Nurs       Date:  2017-01-25       Impact factor: 2.522

4.  Commentary: Age-related neurodegenerative disease research needs aging models.

Authors:  Lindsay M K Wallace; Susan E Howlett
Journal:  Front Aging Neurosci       Date:  2016-01-29       Impact factor: 5.750

Review 5.  Role of Cachexia and Fragility in the Patient Candidate for Cardiac Surgery.

Authors:  Calogera Pisano; Daniele Polisano; Carmela Rita Balistreri; Claudia Altieri; Paolo Nardi; Fabio Bertoldo; Daniele Trombetti; Laura Asta; Maria Sabrina Ferrante; Dario Buioni; Calogero Foti; Giovanni Ruvolo
Journal:  Nutrients       Date:  2021-02-05       Impact factor: 5.717

Review 6.  The Frailty Puzzle: Searching for Immortality or for Knowledge Survival?

Authors:  Stefano Govoni; Francesca Fagiani; Cristina Lanni; Nicola Allegri
Journal:  Front Cell Neurosci       Date:  2022-02-17       Impact factor: 5.505

7.  Short senolytic or senostatic interventions rescue progression of radiation-induced frailty and premature ageing in mice.

Authors:  Edward Fielder; Tengfei Wan; Thomas von Zglinicki; Satomi Miwa; Ghazaleh Alimohammadiha; Abbas Ishaq; Evon Low; B Melanie Weigand; George Kelly; Craig Parker; Brigid Griffin; Diana Jurk; Viktor I Korolchuk
Journal:  Elife       Date:  2022-05-04       Impact factor: 8.713

Review 8.  The impact of frailty on intensive care unit outcomes: a systematic review and meta-analysis.

Authors:  John Muscedere; Braden Waters; Aditya Varambally; Sean M Bagshaw; J Gordon Boyd; David Maslove; Stephanie Sibley; Kenneth Rockwood
Journal:  Intensive Care Med       Date:  2017-07-04       Impact factor: 17.440

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.